Search

everythinglearnresearchcommunity

for

Search:↓

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Minor injuries to hair follicles can stimulate hair growth in mice by increasing a specific protein.

Minor skin injuries can boost hair growth by increasing TNF-α.

Etanercept may not prevent alopecia areata from coming back.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

TNF-alpha inhibitors can cause various immune-related skin issues.

TNF alpha in skin cells causes weight loss, hair and fat issues, and skin inflammation in mice.

Some drugs used to treat inflammation may cause hair loss.

High TNF-α levels may increase hair loss risk after PRP therapy.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

Blocking interferon-gamma might help treat various autoimmune diseases.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Some drugs used to treat immune conditions may cause different types of hair loss.

Adalimumab helped control a child's severe eye disease when other treatments failed.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.